|
Volumn 20, Issue 4, 1999, Pages 197-198
|
DC-based cancer immunotherapy: The sequel [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD4 ANTIGEN;
CD8 ANTIGEN;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
TUMOR ANTIGEN;
ANTIGEN SPECIFICITY;
AUTOIMMUNITY;
CANCER IMMUNOTHERAPY;
CYTOTOXIC T LYMPHOCYTE;
DENDRITIC CELL;
EFFECTOR CELL;
IMMUNE RESPONSE;
IMMUNE SYSTEM;
IMMUNOGENICITY;
IMMUNOLOGICAL TOLERANCE;
IMMUNOSURVEILLANCE;
LETTER;
PRIORITY JOURNAL;
TUMOR CELL;
TUMOR GROWTH;
|
EID: 0032953316
PISSN: 01675699
EISSN: None
Source Type: Journal
DOI: 10.1016/S0167-5699(98)01407-8 Document Type: Letter |
Times cited : (10)
|
References (18)
|